Filing Flows › Inogen (INGN) › Q1 2026 › vs Q4 2025
Inogen (INGN) Q1 2026 vs Q4 2025 (quarter over quarter)
Inogen's revenue rose $3.4M (+4%) from $81.7M in Q4 2025 to $85.1M in Q1 2026.
Inogen, Q1 2026: revenue $85.1M (+3% year over year), operating margin -11.0%, net loss $8.3M, operating cash flow −$6.7M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $85.1M | $81.7M | $3.4M | +4% |
| Other income, net | $838K | $1.9M | −$1.1M | -57% |
| Income tax benefit | $174K | $236K | −$62K | -26% |
| Net loss | $8.3M | $7.1M | $1.2M | +17% |
| Costs & expenses | $94.4M | $91.0M | $3.4M | +4% |
| Operating costs | $94.4M | $91.0M | $3.4M | +4% |
| Cost of revenue | $47.2M | $46.5M | $761K | +2% |
| Research & development | $5.1M | $5.3M | −$219K | -4% |
| Sales & marketing | $24.6M | $23.1M | $1.5M | +6% |
| General & admin | $17.5M | $16.1M | $1.4M | +9% |
| Operating cash sources | $13.5M | $7.8M | $5.8M | +74% |
| Depreciation & amortization | $4.9M | $5.0M | −$131K | -3% |
| Share-based compensation | $1.9M | $1.8M | $139K | +8% |
| Cash used in operations | $6.7M | $943K | $5.7M | +609% |
| Net loss absorbed | $8.3M | $7.1M | $1.2M | +17% |
| Working capital & other | $5.2M | $662K | $4.6M | +688% |
Questions
How much did Inogen's revenue grow quarter over quarter in Q1 2026?
Inogen's revenue rose $3.4M (+4%) from $81.7M in Q4 2025 to $85.1M in Q1 2026.